[23:52] That antimicrobial activity of the lactoferrin is due to two different mechanisms
# De registro SD-US-18-07211
The most frequent adverse effects include gastrointestinal symptoms, appetite loss, tachycardia, pancreatitis, and a possible risk of thyroid tumors, warranting careful monitoring 21,22,23,24
Human use is not FDA-approved, but accumulated clinical experience is reassuring: Common and mild Injection site reaction: mild redness, swelling, tenderness - resolves within hours
PLCAR has documented clinical research in peripheral arterial disease, where it significantly improved walking distance and quality of life measures compared to standard L-Carnitine demonstrating its superiority for vascular smooth muscle energy support in conditions of reduced blood flow